Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations
- PMID: 38965064
- DOI: 10.1111/ijd.17350
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations
Abstract
Yao syndrome (YAOS) is a novel systemic autoinflammatory disease linked to the nucleotide-binding oligomerization domain (NOD2) gene. It is characterized by periodic fevers, gastrointestinal (GI) symptoms, arthritis, and dermatitis, among other symptoms. A sparse literature exists on this disease, and little is known about its dermatological manifestations. A review of available literature was performed to characterize the cutaneous manifestations of Yao syndrome. Cutaneous manifestations were documented in 85.7% of patients, with common characteristic descriptions of erythematous patches and plaques involving the face, trunk, abdomen, and extremities. Based on our review of treatment modalities employed for Yao syndrome, prednisone is an appropriate initial approach, with oral sulfasalazine and other disease-modifying antirheumatic drugs serving as appropriate secondary options. YAOS should be considered in the differential diagnosis of patients presenting with a dermatitic rash, especially in the context of concurrent articular symptoms, periodic fever, and GI symptoms.
Keywords: NOD2; Yao syndrome; autoinflammatory disease; cutaneous manifestations; narrative review.
© 2024 the International Society of Dermatology.
References
-
- Yao Q, Zhou L, Cusumano P, Bose N, Piliang M, Jayakar B, et al. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res Ther. 2011;13(5):R148.
-
- Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2‐associated autoinflammatory disease: a large cohort study. Rheumatology. 2015;54(10):1904–1912.
-
- Rivera EG, Patnaik A, Salvemini J, Jain S, Lee K, Lozeau D, et al. SARS‐CoV‐2/COVID 19 and its relationship with NOD2 and ubiquitination. Clin Immunol. 2022;238:109027.
-
- Trueb B, Zhuang L, Keller I, Kockritz LV, Kuchen S, Dufour JF, et al. Coincidence of NOD2‐associated autoinflammatory disease (Yao Syndrome) and HCV infection with fatal consequences: interaction between genes and environment. J Clin Rheumatol. 2021;27(8S):S592–S594.
-
- Brailsford CJ, Khamdan F, Elston DM. Treatment of refractory Yao syndrome with canakinumab. JAAD Case Rep. 2022;29:37–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
